Curaleaf Holdings, Inc.

CURLF · OTC · Enterprise · SIC 2833 Medicinal Chemicals & Botanical Products

Engine v1.1.0 · live data

Filings through Jun 30, 2026 · 10-Q filed Aug 6, 2026

Price as of Sep 16, 2026 · USD

Valuation method: EV / EBITDA

Revenue (TTM)

$1.3B

EBITDA (TTM, GAAP-derived)

$209.9M

Free cash flow (TTM)

$75.4M

Cash & short-term investments

$94.6M

Total debt

$611.5M

Market capitalization

$2.6B

Enterprise value

$3.2B

EV / EBITDA

15.1×

Dashboard Evidence Room™Opportunities & Approval Financial Lab™Multiple Intelligence™Enterprise Value Study™ Ultimate One-Pager

Opportunity Detection · MultiStrategy™

4 pathways detected from Curaleaf Holdings, Inc.'s own filings

Each pathway fires only when the company's evidence supports it. Scores are deterministic; component scores are shown, the weights stay server-side.

#1NOWIP Monetization·Asset & IP Monetization·5X: Asset Value

IP & Brand Monetization

Curaleaf Holdings, Inc. carries $956.1M of identified intangible assets plus $633.0M of goodwill (56.5% of total assets). Licensing and brand partnerships can earn incremental returns on assets already paid for.

Annual economics

$28.7M–$76.5M

SCENARIO

$956.1M intangibles × 3%–8% royalty-equivalent yield

Evidence that triggered it

Intangible assets (ex-goodwill)$956.1M
Goodwill$633.0M
Total assets$2.8B

Assumptions (challenge these)

Royalty-equivalent EBITDA yield on intangibles3.0%–8.0%ASSUMPTION

Score components

Economic impact100
Feasibility68
Time to value70
Capital efficiency90
Strategic fit55
Evidence strength100

Capital required: None material
Time to value: 9 months
Execution complexity: Medium
Regulatory complexity: Low

HUMAN APPROVAL GATE

DRAFT

Activation is locked until this pathway is reviewed and approved.

#2NEXTAI Enterprise-Value Optimization·Operational Optimization·5X: Enterprise Value

Margin Recovery Program

EBITDA margin has compressed from 19.2% to 16.0% on a trailing basis. On $1.3B of revenue, each point recovered is worth $13.2M of annual EBITDA. Token Clear models recovering part of the 3.2% gap through pricing, mix, procurement and AI-driven operating efficiency.

Annual economics

$10.7M–$25.6M

SCENARIO

$1.3B revenue × 3.2% margin gap × 25%–60% recovered

Evidence that triggered it

EBITDA margin (TTM)16.0%
Revenue (TTM)$1.3B
EBITDA margin FY202419.2%

Assumptions (challenge these)

Share of margin gap recovered25.0%–60.0%ASSUMPTION
Program cost (share of revenue, one-time)0.5%ASSUMPTION

Score components

Economic impact100
Feasibility68
Time to value55
Capital efficiency100
Strategic fit55
Evidence strength100

Capital required: $6.6M
Time to value: 12 months
Execution complexity: Medium
Regulatory complexity: Low

HUMAN APPROVAL GATE

DRAFT

Activation is locked until this pathway is reviewed and approved.

#3NOWStructured Products·Risk & Capital Structure·5X: Capital Value

Structured Refinancing of High-Cost Debt

Implied cost of debt is 8.8% on $611.5M of borrowings. Revenue-participation, convertible or asset-backed structures (including RPCST™-style instruments where permitted) are modeled to lower the all-in cost of capital.

Annual economics

$6.1M–$15.3M

SCENARIO

$611.5M debt × 1.0%–2.5% lower cost

Evidence that triggered it

Total debt$611.5M
Interest expense (TTM)$53.5M
Implied cost of debt8.8%

Assumptions (challenge these)

Reduction in all-in cost of debt1.0%–2.5%ASSUMPTION

Score components

Economic impact100
Feasibility40
Time to value70
Capital efficiency90
Strategic fit55
Evidence strength77

Capital required: None material
Time to value: 9 months
Execution complexity: High
Regulatory complexity: Medium

Blockers & dependencies

Securities-law, lender consent and rating-agency review.

HUMAN APPROVAL GATE

DRAFT

Activation is locked until this pathway is reviewed and approved.

#4NEXTEmployee Capital·Employee Capital·5X: Stakeholder Value

Employee Ownership & Retention Program

Stock-based compensation is $42.8M a year (3.3% of revenue). Participation structures that align employees with measured enterprise outcomes can deliver the same retention with less dilution.

Annual economics

$1.3M–$3.4M

SCENARIO

$42.8M SBC × 3%–8% efficiency

Evidence that triggered it

Stock-based compensation (TTM)$42.8M
Stock comp / revenue3.3%

Assumptions (challenge these)

Compensation efficiency (share of SBC)3.0%–8.0%ASSUMPTION

Score components

Economic impact28
Feasibility60
Time to value55
Capital efficiency90
Strategic fit55
Evidence strength100

Capital required: None material
Time to value: 12 months
Execution complexity: Medium
Regulatory complexity: Medium

HUMAN APPROVAL GATE

DRAFT

Activation is locked until this pathway is reviewed and approved.

Token Clear is modeling the enterprise…

First run for a company pulls filings live from SEC EDGAR. Subsequent loads are cached.

1Resolving issuer on SEC EDGAR
2Building Company Graph™ from XBRL filings
3Pulling market data and live peer set
4Detecting opportunities and scoring MultiStrategy™
5Running deterministic scenarios